Never assume, even with electronic prescriptions
Without due attention, technological advances in health care can mean a heightened risk for pharmacists and patients, PDL warns In its latest practice alert, PDL shares information about avoiding errors …
Creating effective EDM campaigns for pharmacies
Recently, a client in our marketing module reached out for guidance on crafting EDMs (electronic direct mail) that resonate with their community, writes Rebecca Goodsell At Peak, we use EDMs …
Charting the course
PDL has some guidance on Collaborative Pharmacist-led Charting and Prescribing PDL has chosen to describe the charting and prescribing activity by hospital pharmacists as Collaborative Pharmacist-led Charting and Prescribing (CPCP), …
Transitions of care
Transitions of care are pivotal moments in healthcare delivery, where patients move between different healthcare settings Whether transitioning from hospital to home, or from home to an aged-care facility …
November MIMS Update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Dapagliflozin (propanediol monohydrate) and sitagliptin (phosphate monohydrate) (Sidapvia) is a combination of the …
UTIs in the NT
PDL has some advice for pharmacists practising in the Northern Territory Recent legislative change now allows Northern Territory pharmacists to provide antibiotic treatment without a prescription from a prescriber for …
Mandatory reporting: a pharmacist’s responsibilities
Andrew Tooms takes look around the nation at the legislative and regulatory responsibilities of pharmacists when confronted by possible abuse of a minor Author: Andrew Tooms BSc (Hons), LLB, MHM, AACPA, …
Raising awareness of RSV vaccine options, midazolam and Wegovy strengths
PDL has some advice on RSV vaccination, and the strengths of midazolam and Wegovy This Practice Alert highlights some recent practice issues reported to PDL Professional Officers. Respiratory Syncytial Virus …
Have you received an Ahpra notification?
During your healthcare career, you may receive a regulatory notification Regulatory notifications are a mechanism for the public to raise any concerns about their healthcare experience and are an integral …
October MIMS Update
A look at some of the recent changes to the medicines landscape, with new products, presentations, indications and contraindications New Products Selpercatinib (Retevmo) is an orally available, small molecule inhibitor …
Schedule 3 supply of therapeutic vaping products
From 1 October 2024, therapeutic vapes with a nicotine concentration of 20mg/mL or less will be available in pharmacies to patients 18 years or over without a prescription. Date of …
Never again: multi-practitioner perspectives of key medication safety learnings from coroner’s cases
Incidents described in coroner’s reports are an in-depth and factual account of events leading to a tragic outcome and provide an opportunity for clinicians to learn critical lessons These reports …